Cerebrospinal fluid catecholamines in delirium and dementia.

Dopamine and noradrenaline are functionally connected to delirium and have been targets for pharmacological interventions but the biochemical evidence to support this notion is limited. To study the CSF levels of dopamine, noradrenaline and the third catecholamine adrenaline in delirium and dementia, these were quantified in three patient cohorts: (i) cognitively normal elderly patients ( n  = 122); (ii) hip fracture patients with or without delirium and dementia ( n  = 118); and (iii) patients with delirium precipitated by another medical condition (medical delirium, n  = 26). Delirium was assessed by the Confusion Assessment Method. The hip fracture cohort had higher CSF levels of noradrenaline and adrenaline than the two other cohorts (both P  < 0.001). Within the hip fracture cohort those with delirium ( n  = 65) had lower CSF adrenaline and dopamine levels than those without delirium ( n  = 52, P  = 0.03, P  = 0.002). Similarly, the medical delirium patients had lower CSF dopamine levels than the cognitively normal elderly ( P  < 0.001). Age did not correlate with the CSF catecholamine levels. These findings with lower CSF dopamine levels in hip fracture- and medical delirium patients challenge the theory of dopamine excess in delirium and question use of antipsychotics in delirium. The use of alpha-2 agonists with the potential to reduce noradrenaline release needs further examination.